Welcome to our dedicated page for NDAC news (Ticker: NDAC), a resource for investors and traders seeking the latest updates and insights on NDAC stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NDAC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NDAC's position in the market.
NightDragon Acquisition Corp. (NASDAQ: NDAC; NDACW; NDACU) announced on May 28, 2021, that it is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to a delay in filing its quarterly report on Form 10-Q for Q1 2021. The company has 60 days to submit a compliance plan, potentially allowing an extension of up to 180 days if accepted. Additionally, the SEC's statement regarding SPAC warrants may impact the company's financial statements. The notice does not affect current trading of its securities on Nasdaq.
FAQ
What is the market cap of NDAC (NDAC)?
